Brazil plans to expand a crackdown on companies that patent products made from rare plants and animals without adequately compensating the South American country or its indigenous communities.
The fight against “biopiracy” has won the support of indigenous communities and defenders of the Amazon rain forest who say corporations unfairly benefit from medicine and other products derived from Brazil’s exotic plants, poisonous snakes or brightly colored frogs.
However, the effort has sparked criticism that it slows crucial scientific research and arbitrarily targets entrepreneurs that could develop environmentally sustainable businesses.
Brazil has levied more than 100 million reais (US$59 million) in fines since July on companies charged with not paying fair compensation for the use of genetic material native to Brazil, said Bruno Barbosa, who heads inspection for the environmental oversight agency Ibama.
Next year, officials will begin pursuing companies that did not notify the government of their use of local species to create products such as pharmaceuticals, as required by law, meaning fines will likely go up.
“Given that [fighting biopiracy] is a new process and that Brazil has one of the biggest reserves of biodiversity in the world, I think most of this activity is illegal, and we’re going to find those people,” he said.
Barbosa says examples of biopiracy abound, such as the development in the 1970s of the hypertension medication captopril from a snake venom that indigenous groups used on arrowhead tips.
Pharmaceuticals companies also used the yellow-and-green Kambo frog, found in Brazil’s Amazon state of Acre, to create anti-inflammatory drugs without distributing benefits to local residents, he said. Many of these incidents came before a 2001 decree that created the current rules governing species use.
The government this year stepped up the anti-biopiracy effort with a campaign known as “Operation New Direction” that aims to crack down on what it calls profiteering.
Fines next year may rise to US$29 million each and companies face possible cancelation of patents in Brazil if inspectors find they did not register the use of local species.
One of the biggest fines levied so far was on Brazil’s largest cosmetics maker Natura, Barbosa said. He declined to give details on the amount or the infraction because the process is ongoing.
Critics say Brazil’s often aggressive efforts to prevent biopiracy threaten to slow crucial scientific research that could provide new cancer treatments or remedies for diseases suffered by local populations.
They said it treats anyone interested in commercial use of rare species as possibly criminal, complicating government goals of developing research facilities near where the species are found to create jobs in those communities.
The government should make the rules clearer because the current system ends up penalizing those that make the most effort to be transparent about their use of genetic material, said Raul Telles do Valle who works with ISA, a think tank on social and environmental issues.
“The current law is very vague on a lot of points, it ends up classifying everybody as illegitimate,” he said. “Just passing out fines under the existing framework isn’t going to solve the problem.”
The law should reflect the difficulty of determining how to compensate local populations from collective knowledge passed down over generations, he said.
Barbosa says the government’s legislation is suitable and that expanding the fight against biopiracy could reduce the destruction of sensitive environments.
“This is going to enable concrete alternatives that substitute destruction of the ecosystem for new economic mechanisms,” he said.
ISSUES: Gogoro has been struggling with ballooning losses and was recently embroiled in alleged subsidy fraud, using Chinese-made components instead of locally made parts Gogoro Inc (睿能創意), the nation’s biggest electric scooter maker, yesterday said that its chairman and CEO Horace Luke (陸學森) has resigned amid chronic losses and probes into the company’s alleged involvement in subsidy fraud. The board of directors nominated Reuntex Group (潤泰集團) general counsel Tamon Tseng (曾夢達) as the company’s new chairman, Gogoro said in a statement. Ruentex is Gogoro’s biggest stakeholder. Gogoro Taiwan general manager Henry Chiang (姜家煒) is to serve as acting CEO during the interim period, the statement said. Luke’s departure came as a bombshell yesterday. As a company founder, he has played a key role in pushing for the
China has claimed a breakthrough in developing homegrown chipmaking equipment, an important step in overcoming US sanctions designed to thwart Beijing’s semiconductor goals. State-linked organizations are advised to use a new laser-based immersion lithography machine with a resolution of 65 nanometers or better, the Chinese Ministry of Industry and Information Technology (MIIT) said in an announcement this month. Although the note does not specify the supplier, the spec marks a significant step up from the previous most advanced indigenous equipment — developed by Shanghai Micro Electronics Equipment Group Co (SMEE, 上海微電子) — which stood at about 90 nanometers. MIIT’s claimed advances last
CROSS-STRAIT TENSIONS: The US company could switch orders from TSMC to alternative suppliers, but that would lower chip quality, CEO Jensen Huang said Nvidia Corp CEO Jensen Huang (黃仁勳), whose products have become the hottest commodity in the technology world, on Wednesday said that the scramble for a limited amount of supply has frustrated some customers and raised tensions. “The demand on it is so great, and everyone wants to be first and everyone wants to be most,” he told the audience at a Goldman Sachs Group Inc technology conference in San Francisco. “We probably have more emotional customers today. Deservedly so. It’s tense. We’re trying to do the best we can.” Huang’s company is experiencing strong demand for its latest generation of chips, called
GLOBAL ECONOMY: Policymakers have a choice of a small 25 basis-point cut or a bold cut of 50 basis points, which would help the labor market, but might reignite inflation The US Federal Reserve is gearing up to announce its first interest rate cut in more than four years on Wednesday, with policymakers expected to debate how big a move to make less than two months before the US presidential election. Senior officials at the US central bank including Fed Chairman Jerome Powell have in recent weeks indicated that a rate cut is coming this month, as inflation eases toward the bank’s long-term target of two percent, and the labor market continues to cool. The Fed, which has a dual mandate from the US Congress to act independently to ensure